To order this detailed 320+ page report, please visit this -
https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
Key Inclusions
§
A detailed assessment
of the current market landscape with respect to the players (industry and
non-industry) involved in manufacturing radiopharmaceuticals. It features
information on the year of establishment, company size, purpose of production
(fulfilling in-house requirements / for contract services), location of
headquarters, location of manufacturing facilities, scale of production,
applications of radiopharmaceuticals (in diagnosis, therapeutics and
theranostics), type of diagnostic radiopharmaceuticals (PET and SPECT), type of
therapeutic radiopharmaceuticals (alpha emitters, beta emitters and others),
target therapeutic area (cardiology, oncology, neurology, thyroid and others)
and services offered.
§
An insightful
four-dimensional comparison of the radiopharmaceutical manufacturers, based on
supplier power (year of establishment), product portfolio (number of isotopes
being manufactured for various applications targeting different therapeutic
areas) of the manufacturer, scale at which they manufacture their respective
products and company size.
§
Tabulated profiles of
key industry players based in North America, Europe and Asia-Pacific
(shortlisted based on the company size of the players), featuring a brief
overview of the company, a list of products and manufacturing facilities,
recent developments and an informed future outlook.
§
An analysis of recent
partnerships and collaborations inked in this domain since 2017, based on
several parameters, such as the type of partnership, year of partnership, type
of radioisotope involved, therapeutic area mentioned in the agreement, application of the radioisotope mentioned in
the agreement, and a schematic representation showcasing the players that have
forged the maximum number of alliances. Furthermore, we have provided a world
map representation of the deals inked in this field, highlighting those that
have been established within and across different continents.
§
A detailed discussion
on the supply chain model of medical isotope Mo-99 (Tc-99m), highlighting the
main steps of the supply chain, from irradiation of uranium targets in nuclear
research reactors to the administration of Tc-99m to patients. Along with this,
it describes the structure of the industry and product market at each step.
The report also features the likely distribution
of the current and forecasted opportunity across important market segments,
mentioned below:
§
Target Therapeutic Area
§
Cardiology
§
Neurology
§
Oncology
§
Thyroid
§
Others
§
Diagnostic
§
Therapeutic
§
Type of Diagnostic Radiopharmaceuticals
§
PET
§
SPECT
§
Type of Therapeutic Radiopharmaceuticals
§
Alpha Emitters
§
Beta Emitters
§
Others
§
Purpose of Production
§
In-House
§
Outsourcing
§
North America
§
Europe
§
Asia-Pacific and the Rest of the World
Transcripts
of interviews held with the following senior level representatives of
stakeholder companies
§
J
James
Davis, Vice President Quality / R&D, Shertech Laboratories
§ Andreas
Fotopoulos, Professor of Nuclear Medicine, University of Ioannina Medical School
§ Jan
Pruim, Professor of Medical Imaging / Nuclear Medicine Physician, University
Medical Center of Groningen
§ Michael
van Dam, Professor, Crump Institute for Molecular Imaging, Molecular &
Medical Pharmacology
§
Anonymous, ITM Isotopen Technologien München
To request sample pages, please visit this -
https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing/request-sample.html
Key Questions Answered
§
Who are
the leading industry and non-industry players engaged in the nuclear medicine
and radiopharmaceutical manufacturing market?
§
For which application and disease indications are the
radiopharmaceuticals being manufactured?
§
What are the various type of radionuclides being
manufactured for the formulation of radiopharmaceuticals?
§
What is the relative competitiveness of manufacturers
involved in the nuclear medicine and radiopharmaceutical manufacturing?
§
Which partnership models are commonly adopted by the
radiopharmaceutical manufacturers in this industry?
§
What is the supply chain process for medical isotope Mo-99
/ Tc-99m?
§
What are the key factors that are likely to influence the
evolution of the nuclear medicine and radiopharmaceutical manufacturing
market?
§
How is the current and future market opportunity likely to
be distributed across key market segments?
You may also be interested in the following titles:
1.
High Energy Chemistry / Hazardous Chemistry-based API
Manufacturing Services Market: Focus on
High Temperature, Low Temperature / Cryogenic, High Pressure and Low Pressure
Chemistries, 2020-2030
2.
Live Biotherapeutic Products and Microbiome Contract
Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030
3.
China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030
4.
Continuous
Manufacturing Market
(Small Molecules and Biologics), 2020 – 2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com